Washington University in St. Louis at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Washington University in St. Louis brings 4 presentations to ASH 2026 in New Orleans. Its program centres on clotting and bleeding, from the structural biology of clot formation and breakdown to new antiplatelet drugs and extensive deep vein thrombosis. It also covers novel lymphoma therapies for community oncologists and transplant for severe inherited hemolytic anemias.
| Organization | ASH 2026 Attendance |
|---|---|
Washington University in St. Louis St. Louis, MO | |
Private research university in St. Louis, Missouri, including the WashU School of Medicine. | Symposium Fri Dec 11 7:00pm–10:00pm Addressing Community Oncologists’ Questions About Novel Therapies in Non-Hodgkin Lymphoma – What Clinicians Want To Know: A CME-Accredited Friday Satellite Symposium Preceding the 68th ASH Annual Meeting Answers to community oncologists' most pressing questions about new drugs for non-Hodgkin lymphoma, drawn from a survey and reviewed against current research. Symposium Fri Dec 11 11:00am–2:00pm Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials. Session Special Symposium on the Basic Science of Hemostasis and Thrombosis (SSBSHT) New tools including multiomics, protein design, functional genomics, and AI applied to how blood clots form and dissolve, and to bleeding disorders. Talk Structural Insights into Mechanisms How an enzyme chemically modifies vitamin K dependent proteins, and how that step shapes blood clotting control, bone building, and blood vessel signaling. Session Rethinking Antiplatelet Strategies: Selective Blockade, Broad-Acting Drugs, and Beyond Safer clot prevention by selectively blocking the platelet signals that grow a clot, instead of shutting platelets down and raising bleeding risk. Talk Vascular Anomalies: Understanding the Healthcare Experiences of Patients and Caregivers What living with a rare vascular anomaly involves, from long diagnostic journeys and stigma to scarce experts, and how clinicians can help. Talk Hematopoietic Stem Cell Transplantation in Severe Congenital Hemolytic Anemias Using stem cell transplants from matched or mismatched donors, now safer, to cure severe inherited hemolytic anemias, even in very young children. Talk Update on the management of Extensive DVT Recent trials on managing extensive deep vein thrombosis, and which patients benefit from catheter-directed clot removal for acute or chronic clots. |
Instantly find 20 buyers from Washington University in St. Louis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction